|Articles|October 24, 2022
How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology, and Vaccines
Author(s)Emergent CDMO
Many CDMOs outsource their nanoparticle supply chain, but in house manufacturing of nanoparticles at CDMOs is anticipated to create new market opportunities.
Related Content